Khê Hoang‐Xuan
- Genetics top 0.01%
- Neurology top 0.1%
- Molecular Biology top 1%
- Pulmonary and Respiratory Medicine top 0.5%
- Pathology and Forensic Medicine top 0.1%
- Co-authors
- Jean‐Yves DelattreMarc SansonKarima MokhtariAhmed IdbaïhAlain CarpentierFrançois DucrayYannick MarieOlivier Chinot
- Topics
- Glioma Diagnosis and Treatment (233 papers)CNS Lymphoma Diagnosis and Treatment (112 papers)Lymphoma Diagnosis and Treatment (79 papers)
- Cited by
- GeneticsNeurologyCancer Research
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Khê Hoang‐Xuan
312 papers receiving 17.0k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Genetics 11.2k
- Neurology 4.6k
- Molecular Biology 4.5k
- Pulmonary and Respiratory Medicine 4.0k
- Pathology and Forensic Medicine 3.3k
Countries citing papers authored by Khê Hoang‐Xuan
This map shows the geographic impact of Khê Hoang‐Xuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khê Hoang‐Xuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khê Hoang‐Xuan more than expected).
Fields of papers citing papers by Khê Hoang‐Xuan
This network shows the impact of papers produced by Khê Hoang‐Xuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khê Hoang‐Xuan. The network helps show where Khê Hoang‐Xuan may publish in the future.
Co-authorship network of co-authors of Khê Hoang‐Xuan
This figure shows the co-authorship network connecting the top 25 collaborators of Khê Hoang‐Xuan. A scholar is included among the top collaborators of Khê Hoang‐Xuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khê Hoang‐Xuan. Khê Hoang‐Xuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 11 | |
| 6 | 12 | |
| 7 | 1 | |
| 8 | 43 | |
| 9 | 21 | |
| 10 | 25 | |
| 11 | 5 | |
| 12 | 81 | |
| 13 | FINAL EFFICACY AND SAFETY RESULTS FROM AVAglio, A PHASE III TRIAL OF BEVACIZUMAB (BEV) PLUS TEMOZOLOMIDE (TMZ) ANDRADIOTHERAPY (RT) IN NEWLY DIAGNOSED GLIOBLASTOMA | 3 |
| 14 | Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951breakdown → | 804 |
| 15 | LONG-TERM FOLLOW-UP OF EORTC 26951, A RANDOMIZED TRIAL ON ADJUVANT PCV CHEMOTHERAPY IN ANAPLASTIC OLIGODENDROGLIAL TUMORS. A REPORT OF THE EORTC BTG. | 0 |
| 16 | 24 | |
| 17 | 402 | |
| 18 | Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomasbreakdown → | 773 |
| 19 | Vers une classification moléculaire des gliomes | 6 |
| 20 | Biologie et thérapie génique des gliomes. | 0 |
About Khê Hoang‐Xuan
Khê Hoang‐Xuan is a scholar working on Genetics, Neurology and Pathology and Forensic Medicine, having authored 331 papers that have together received 17.3k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (233 papers), CNS Lymphoma Diagnosis and Treatment (112 papers) and Lymphoma Diagnosis and Treatment (79 papers). The work is most often cited by research in Genetics (11.2k citations), Neurology (4.6k citations) and Cancer Research (3.2k citations). Khê Hoang‐Xuan has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Jean‐Yves Delattre, Marc Sanson, Karima Mokhtari, Ahmed Idbaïh, Alain Carpentier, François Ducray, Yannick Marie, Olivier Chinot, Alba A. Brandes and Roger Henriksson. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.